Medicine
Rasagiline 0.5 mg tablet
Rasagiline 0.5 mg tablet is a generic prescription medicine for oral use, made by 15 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C…
Key facts
- Active ingredient (INN)
- Rasagiline
- Brand
- Sold under the generic name
- Strength
- 0.5 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets, 500 tablets, 1000 tablets and 20 more
- Manufacturers
- Micro LabsIndiaTorrent PharmaceuticalsIndiaAscend LaboratoriesIndiaAurobindo PharmaIndiaMacleods PharmaceuticalsIndiaCarnegie PharmaceuticalsSKG PharmaAlvogenChartwell RXFlorida Pharmaceutical Products
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N04BD02 Rasagiline
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 3 January 2017
- Identifiers
- RxCUI 608328, 636664DailyMed set ID 5c234b28-29e7-4149-9505-e2818a692bca, 42f8d62f-2c57-47bc-92e7-b28111aa8cd1, 7d9eac3f-7441-45cf-a603-ea18c116e2c0 +12NDC 83085-007, 42571-220, 64980-711 +12Application ANDA218163, ANDA207004, ANDA201892 +8
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet in 1 bottle | 67877-259-30 | Ascend LaboratoriesIndia | 30 October 2017 |
| 30 tablet in 1 bottle | 84386-169-30 | Aurobindo PharmaIndia | 20 October 2026 |
| 30 tablet in 1 bottle | 33342-308-07 | Macleods PharmaceuticalsIndia | 29 June 2024 |
| 500 tablet in 1 bottle | 42571-220-05 | Micro LabsIndia | 3 April 2019 |
| 1000 tablet in 1 bottle | 42571-220-10 | Micro LabsIndia | 3 April 2019 |
| 30 tablet in 1 bottle | 42571-220-30 | Micro LabsIndia | 3 April 2019 |
| 500 tablet in 1 container | 13668-447-05 | Torrent PharmaceuticalsIndia | 15 November 2025 |
| 30 tablet in 1 container | 13668-447-30 | Torrent PharmaceuticalsIndia | 15 November 2025 |
| 90 tablet in 1 container | 13668-447-90 | Torrent PharmaceuticalsIndia | 15 November 2025 |
| 30 tablet in 1 bottle, plastic | 47781-683-30 | Alvogen | 1 March 2019 |
| 30 tablet in 1 bottle | 80005-141-08 | Carnegie Pharmaceuticals | 15 January 2026 |
| 90 tablet in 1 bottle | 80005-141-10 | Carnegie Pharmaceuticals | 15 January 2026 |
| 500 tablet in 1 bottle | 80005-141-14 | Carnegie Pharmaceuticals | 15 January 2026 |
| 30 tablet in 1 bottle | 62135-676-30 | Chartwell RX | 1 May 2024 |
| 30 tablet in 1 bottle | 71921-407-33 | Florida Pharmaceutical Products | 14 April 2026 |
| 30 tablet in 1 bottle | 64980-711-30 | Rising Pharma Holdings | 21 July 2025 |
| 1000 tablet in 1 bottle | 83085-007-10 | SKG Pharma | 4 April 2025 |
| 30 tablet in 1 bottle | 83085-007-30 | SKG Pharma | 4 April 2025 |
| 500 tablet in 1 bottle | 83085-007-50 | SKG Pharma | 4 April 2025 |
| 30 tablet in 1 bottle | 0093-3060-56 | Teva Pharmaceuticals | 3 January 2017 |
| 30 tablet in 1 bottle | 51407-008-30 | Golden State Medical Supply | 6 April 2026 |
| 30 tablet in 1 bottle | 16714-770-01 | NorthStar RxLLC | 17 April 2018 |
| 50 pouch in 1 box / 1 tablet in 1 pouch | 70518-4683-0 | Remedyrepack | 26 June 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Rasagiline 0.5 mg tablet.
Other strengths and forms of Rasagiline
Clinical summary
Rasagiline is a monoamine oxidase inhibitor indicated for the treatment of Parkinson’s disease (PD). It is available as tablets for oral use. MedsAcross supplies Rasagiline for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about RasagilineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Rasagiline prescribing information (Teva Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Azilect: European public assessment report (EPAR) · European Medicines Agency
- Rasagiline ratiopharm: European public assessment report (EPAR) · European Medicines Agency
Need Rasagiline 0.5 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.